A Beneficial Effect of Low-Dose Aspirin in a Murine Model of Active Tuberculosis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Beneficial Effect of Low-Dose Aspirin in a Murine Model of Active Tuberculosis
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-04-23
DOI
10.3389/fimmu.2018.00798
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Host-directed therapies for bacterial and viral infections
- (2017) Stefan H. E. Kaufmann et al. NATURE REVIEWS DRUG DISCOVERY
- Response to Trypanosoma cruzi by Human Blood Cells Enriched with Dentritic Cells Is Controlled by Cyclooxygenase-2 Pathway
- (2017) Sandra C. H. Lonien et al. Frontiers in Microbiology
- Non-Steroidal Anti-inflammatory Drugs As Host-Directed Therapy for Tuberculosis: A Systematic Review
- (2017) Vera M. Kroesen et al. Frontiers in Immunology
- Associations between systemic inflammation, mycobacterial loads in sputum and radiological improvement after treatment initiation in pulmonary TB patients from Brazil: a prospective cohort study
- (2016) Eliene D. D. Mesquita et al. BMC INFECTIOUS DISEASES
- Inflammation and the coagulation system in tuberculosis: Tissue Factor leads the dance
- (2016) Nadia Caccamo et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Inflammatory signaling in human tuberculosis granulomas is spatially organized
- (2016) Mohlopheni J Marakalala et al. NATURE MEDICINE
- Pulmonary Tuberculosis in Humanized Mice Infected with HIV-1
- (2016) Rebecca J. Nusbaum et al. Scientific Reports
- Tuberculosis
- (2016) Madhukar Pai et al. Nature Reviews Disease Primers
- CD5L/AIM Regulates Lipid Biosynthesis and Restrains Th17 Cell Pathogenicity
- (2015) Chao Wang et al. CELL
- Host-Directed Therapies for Tackling Multi-Drug Resistant Tuberculosis: Learning From the Pasteur-Bechamp Debates: Table 1.
- (2015) Alimuddin Zumla et al. CLINICAL INFECTIOUS DISEASES
- Tissue factor expression by myeloid cells contributes to protective immune response against Mycobacterium tuberculosis infection
- (2015) Sambasivan Venkatasubramanian et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Lipoxins and aspirin-triggered lipoxins in resolution of inflammation
- (2015) Mario Romano et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- AIM/CD5L: a key protein in the control of immune homeostasis and inflammatory disease
- (2015) Lucía Sanjurjo et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The Inflammatory Actions of Coagulant and Fibrinolytic Proteases in Disease
- (2015) Michael Schuliga MEDIATORS OF INFLAMMATION
- Unique role for ATG5 in neutrophil-mediated immunopathology during M. tuberculosis infection
- (2015) Jacqueline M. Kimmey et al. NATURE
- Towards host-directed therapies for tuberculosis
- (2015) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- The PGE2/IL-10 Axis Determines Susceptibility of B-1 Cell-Derived Phagocytes (B-1CDP) to Leishmania major Infection
- (2015) Angélica F. Arcanjo et al. PLoS One
- Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review
- (2015) Dilara Kiran et al. Seminars in Immunopathology
- Alteration of serum inflammatory cytokines in active pulmonary tuberculosis following anti-tuberculosis drug therapy
- (2014) Imran Hussain Chowdhury et al. MOLECULAR IMMUNOLOGY
- Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
- (2014) Katrin D. Mayer-Barber et al. NATURE
- Neutrophils Increase or Reduce Parasite Burden in Trypanosoma cruzi-Infected Macrophages, Depending on Host Strain: Role of Neutrophil Elastase
- (2014) Tatiana Luna-Gomes et al. PLoS One
- Role of Tissue Factor in Mycobacterium tuberculosis-Induced Inflammation and Disease Pathogenesis
- (2014) Hema Kothari et al. PLoS One
- Microenvironments in Tuberculous Granulomas Are Delineated by Distinct Populations of Macrophage Subsets and Expression of Nitric Oxide Synthase and Arginase Isoforms
- (2013) J. T. Mattila et al. JOURNAL OF IMMUNOLOGY
- Low-Dose Aspirin and Ibuprofen's Sterilizing Effects on Mycobacterium tuberculosis Suggest Safe New Adjuvant Therapies for Tuberculosis
- (2013) D. P. Eisen et al. JOURNAL OF INFECTIOUS DISEASES
- Ibuprofen Therapy Resulted in Significantly Decreased Tissue Bacillary Loads and Increased Survival in a New Murine Experimental Model of Active Tuberculosis
- (2013) Cristina Vilaplana et al. JOURNAL OF INFECTIOUS DISEASES
- Nonsteroidal Antiinflammatory Drugs for Adjunctive Tuberculosis Treatment
- (2013) Juraj Ivanyi et al. JOURNAL OF INFECTIOUS DISEASES
- Host-Directed Therapeutics for Tuberculosis: Can We Harness the Host?
- (2013) T. R. Hawn et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- The Scavenger Protein Apoptosis Inhibitor of Macrophages (AIM) Potentiates the Antimicrobial Response against Mycobacterium tuberculosis by Enhancing Autophagy
- (2013) Lucía Sanjurjo et al. PLoS One
- Damaging role of neutrophilic infiltration in a mouse model of progressive tuberculosis
- (2013) Elena Marzo et al. TUBERCULOSIS
- Manifold beneficial effects of acetyl salicylic acid and nonsteroidal anti-inflammatory drugs on sepsis
- (2012) Damon P. Eisen INTENSIVE CARE MEDICINE
- Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events
- (2010) Graeme J Hankey et al. LANCET NEUROLOGY
- Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis
- (2010) Maziar Divangahi et al. NATURE IMMUNOLOGY
- Differential cytokine secretion and early treatment response in patients with pulmonary tuberculosis
- (2009) J. F. Djoba Siawaya et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2and LXA4in the induction of macrophage death
- (2008) Minjian Chen et al. JOURNAL OF EXPERIMENTAL MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started